Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Carcinoma, Squamous Cell × osimertinib × Clear all

Phase

Status

Recruiting 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 40 Lung Neoplasms 15 Neoplasms 2 NSCLC 2 Breast Neoplasms 2 Brain Neoplasms 2 Triple Negative Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumor, Adult 1 Sexual Dysfunction, Physiological 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Non-Small Cell Lung Cancer With EGFR Mutation 1 Non Small Cell Lung Cancer Metastatic 1 NSCLC Patients With Brain Metastasis 1 Multiple Endocrine Neoplasia Type 2a 1 Mesothelioma 1 Meningeal Carcinomatosis 1 Lung Cancer Metastatic 1 Locally Advanced or Metastatic Non-squamous NSCLC 1 Locally Advanced or Metastatic EGFRm Non-small Cell Lung Cancer (NSCLC) 1 Lethal Congenital Contracture Syndrome 2 1 Head and Neck Neoplasms 1 Eunuchism 1 Erectile Dysfunction 1 Diabetes Mellitus, Insulin-Dependent, 12 1 Colorectal Neoplasms 1 Carcinoma, Squamous Cell 1 Carcinoma 1 Advanced Solid Tumors 1 Adenocarcinoma of Lung 1

Interventions

pembrolizumab 13 Carboplatin 10 Cisplatin 9 Docetaxel 6 Paclitaxel 5 Cetuximab 5 Blood Specimen Collection 4 atezolizumab 3 Radiotherapy, Intensity-Modulated 3 Nivolumab 3 toripalimab 2 cemiplimab 2 alpha-2'-deoxythioguanosine 2 Tiragolumab 2 Radiotherapy 2 Drug Therapy 2 tocilizumab 1 regorafenib 1 osimertinib 1 niraparib 1 lenvatinib 1 fludarabine 1 ficlatuzumab 1 dostarlimab 1 calcipotriene 1 bintrafusp alfa protein, human 1 avelumab 1 aldesleukin 1 aflibercept 1 Vinorelbine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06383728 2024-05-09

GALAXY-02

The First Affiliated Hospital of Guangzhou Medical University

Phase 2 Recruiting

Carcinoma, Squamous Cell, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡